OncoCyte Corporation (LON:0KCC)
2.768
+0.003 (0.11%)
At close: Feb 19, 2025
OncoCyte Employees
As of December 31, 2023, OncoCyte had 46 total employees, including 43 full-time and 3 part-time employees. The number of employees decreased by 30 or -39.47% compared to the previous year.
Employees
46
Change (1Y)
-30
Growth (1Y)
-39.47%
Revenue / Employee
11.76K GBP
Profits / Employee
-723.05K GBP
Market Cap
44.15M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 89,900 |
GSK plc | 70,212 |
Haleon | 25,408 |
Smith & Nephew | 18,452 |
Hikma Pharmaceuticals | 9,100 |
ConvaTec Group | 10,136 |
HUTCHMED (China) | 1,988 |
Genus | 3,500 |
OncoCyte News
- 8 days ago - AWM Investment Company, Inc. Increases Stake in OncoCyte Corp - GuruFocus
- 12 days ago - Oncocyte to Participate in BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference - GlobeNewsWire
- 13 days ago - Oncocyte prices $29.1M equity offering - Seeking Alpha
- 6 weeks ago - Oncocyte names Paul Billings as consulting chief medical officer - Seeking Alpha
- 6 weeks ago - Oncocyte Appoints Dr. Paul Billings as Consulting Chief Medical Officer - GlobeNewsWire
- 6 weeks ago - Oncocyte Expands Market Opportunity for VitaGraft™ Kidney - GlobeNewsWire
- 2 months ago - Oncocyte to Participate in "J.P. Morgan Week" and Host Investor Meetings - Benzinga
- 3 months ago - OncoCyte Corporation (OCX) Q3 2024 Earnings Call Transcript - Seeking Alpha